The Potential of Physicochemical and Immunochemical Assays to Replace Animal Tests in the Quality Control of Toxoid Vaccines

This is the 61st report of a series of workshops organised by the European Centre for the Validation of Alternative Methods (ECVAM). The main goal of ECVAM, as defined in 1993 by its Scientific Advisory Committee, is to promote the scientific and regulatory acceptance of alternative methods which have scientific relevance and which reduce, refine or replace the use of laboratory animals. One of the first priorities set by ECVAM was the implementation of procedures that would enable it to become well informed about the stateof-the-art of non-animal test development and validation, and the potential for the possible incorporation of alternative tests into regulatory procedures. It was decided that this would be best achieved by the organisation of ECVAM workshops on specific topics, at which groups of invited experts would review the current status of non animalbased tests and their potential uses, and make recommendations about the best ways forward (1). The workshop on the potential of physicochemical and immunochemical assays to replace animal tests in the quality control of toxoid vaccines was held at ECVAM on 14–15 April 2005, under the cochairmanship of Coenraad Hendriksen and Gideon Kersten. The objectives of the workshop were: a) to review the state-of-the-art of physicochemical, biochemical and immunochemical tests for the quality control of diphtheria and tetanus toxoid vaccines; and b) to identify possibilities for and limitations to their use in the regulatory framework, i.e. for replacing the use of in vivo tests. The outcome of the discussions and the recommendations of the workshop participants are summarised in this report.

[1]  L. Peek,et al.  Effects of Adsorption to Aluminum Salt Adjuvants on the Structure and Stability of Model Protein Antigens* , 2005, Journal of Biological Chemistry.

[2]  T. Arvinte,et al.  Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: correlation with antibody vaccine immunogenicity. , 2005, Vaccine.

[3]  Effects of lowering the aluminium content of a dTpa vaccine on its immunogenicity and reactogenicity when given as a booster to adolescents. , 2005, Vaccine.

[4]  Anthony Mire-Sluis,et al.  Characterizing biological products and assessing comparability following manufacturing changes , 2004, Nature Biotechnology.

[5]  F. Regnier,et al.  Effect of microenvironment pH of aluminum hydroxide adjuvant on the chemical stability of adsorbed antigen. , 2004, Vaccine.

[6]  W. Hennink,et al.  Identification of Formaldehyde-induced Modifications in Proteins , 2004, Journal of Biological Chemistry.

[7]  W. Hennink,et al.  Physicochemical and immunochemical techniques predict the quality of diphtheria toxoid vaccines. , 2003, Vaccine.

[8]  V. Ghole,et al.  Comparative quantitation for the protein content of diphtheria and tetanus toxoids by DC protein assay and Kjeldahl method. , 2003, Biologicals : journal of the International Association of Biological Standardization.

[9]  Bernard Metz,et al.  Reduction of animal use in human vaccine quality control: opportunities and problems. , 2002, Vaccine.

[10]  D. Sesardic Alternatives in testing of bacterial toxins and antitoxins. , 2002, Developments in biologicals.

[11]  K. Weisser,et al.  In vitro determination of specific toxicity in tetanus vaccines. , 2002, Developments in biologicals.

[12]  H. Käyhty,et al.  Immunogenicity and reactogenicity of diphtheria, tetanus and pertussis toxoids combined with inactivated polio vaccine, when administered concomitantly with or as a diluent for a Hib conjugate vaccine. , 2001, Vaccine.

[13]  T. Cyr,et al.  A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products. , 2001, Biologicals : journal of the International Association of Biological Standardization.

[14]  J. White,et al.  Degree of antigen adsorption in the vaccine or interstitial fluid and its effect on the antibody response in rabbits. , 2001, Vaccine.

[15]  D. Sesardic,et al.  Monitoring of diphtheria, pertussis and tetanus toxoids by circular dichroism, fluorescence spectroscopy and size-exclusion chromatography. , 2000, Developments in biologicals.

[16]  C. Frech,et al.  Physicochemical analysis of purified diphtheria toxoids: is toxoided then purified the same as purified then toxoided? , 2000, Developments in biologicals.

[17]  Gupta,et al.  Aluminum compounds as vaccine adjuvants. , 1998, Advanced drug delivery reviews.

[18]  K. Zoon,et al.  Definition of a well-characterized biotechnology product. , 1998, Developments in biological standardization.

[19]  E. London,et al.  Comparison of the conformation, hydrophobicity, and model membrane interactions of diphtheria toxin to those of formaldehyde-treated toxin (diphtheria toxoid): formaldehyde stabilization of the native conformation inhibits changes that allow membrane insertion. , 1996, Biochemistry.

[20]  R. Gupta,et al.  Adjuvants for human vaccines--current status, problems and future prospects. , 1995, Vaccine.

[21]  R. Rappuoli,et al.  Formaldehyde treatment of proteins can constrain presentation to T cells by limiting antigen processing , 1994, Infection and immunity.

[22]  H. Aggerbeck,et al.  Detoxification of diphtheria and tetanus toxin with formaldehyde. Detection of protein conjugates. , 1992, Biologicals : journal of the International Association of Biological Standardization.

[23]  A. T. Glenny,et al.  Diphtheria Toxoid as an Immunising Agent. , 1923 .